Addex Therapeutics Ltd (ADXN)
8.23
+0.85
(+11.52%)
USD |
NASDAQ |
Nov 21, 16:00
8.23
0.00 (0.00%)
After-Hours: 19:50
Addex Therapeutics Market Cap: 8.795M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 7.887M |
| November 19, 2024 | 8.518M |
| November 18, 2024 | 8.453M |
| November 15, 2024 | 8.614M |
| November 14, 2024 | 8.763M |
| November 13, 2024 | 9.223M |
| November 12, 2024 | 9.372M |
| November 11, 2024 | 11.52M |
| November 08, 2024 | 11.27M |
| November 07, 2024 | 11.37M |
| November 06, 2024 | 11.77M |
| November 05, 2024 | 11.84M |
| November 04, 2024 | 11.71M |
| November 01, 2024 | 11.44M |
| October 31, 2024 | 10.42M |
| October 30, 2024 | 11.46M |
| October 29, 2024 | 11.13M |
| October 28, 2024 | 11.77M |
| October 25, 2024 | 11.77M |
| October 24, 2024 | 12.35M |
| October 23, 2024 | 11.61M |
| October 22, 2024 | 11.40M |
| October 21, 2024 | 11.01M |
| October 18, 2024 | 11.16M |
| October 17, 2024 | 11.33M |
| Date | Value |
|---|---|
| October 16, 2024 | 11.27M |
| October 15, 2024 | 11.17M |
| October 14, 2024 | 11.22M |
| October 11, 2024 | 10.96M |
| October 10, 2024 | 11.05M |
| October 09, 2024 | 10.94M |
| October 08, 2024 | 11.05M |
| October 07, 2024 | 9.977M |
| October 04, 2024 | 10.09M |
| October 03, 2024 | 10.05M |
| October 02, 2024 | 9.918M |
| October 01, 2024 | 9.864M |
| September 30, 2024 | 10.44M |
| September 27, 2024 | 9.672M |
| September 26, 2024 | 10.29M |
| September 25, 2024 | 10.63M |
| September 24, 2024 | 10.91M |
| September 23, 2024 | 11.33M |
| September 20, 2024 | 10.52M |
| September 19, 2024 | 10.33M |
| September 18, 2024 | 10.25M |
| September 17, 2024 | 10.83M |
| September 16, 2024 | 10.79M |
| September 13, 2024 | 10.30M |
| September 12, 2024 | 10.91M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.324M
Minimum
Nov 09 2023
106.92M
Maximum
Dec 24 2020
28.26M
Average
22.29M
Median
Jun 10 2022
Market Cap Benchmarks
| AC Immune SA | 325.03M |
| CRISPR Therapeutics AG | 3.952B |
| NLS Pharmaceutics Ltd | 12.93M |
| Molecular Partners AG | 196.71M |
| MoonLake Immunotherapeutics | 3.280B |
Market Cap Related Metrics
| PS Ratio | 7.837 |
| Price to Book Value | 0.6249 |
| Price | 8.23 |
| Earnings Yield | -19.96% |